Intersegment Recombination During Influenza A Virus Replication Gives Rise to a Novel Class of Defective Viral Genomes
- PMID: 40573447
- PMCID: PMC12197472
- DOI: 10.3390/v17060856
Intersegment Recombination During Influenza A Virus Replication Gives Rise to a Novel Class of Defective Viral Genomes
Abstract
Influenza A virus (IAV) is a highly diverse pathogen with genetic variability primarily driven by mutation and reassortment. Using next-generation sequencing (NGS), we characterised defective viral genomes (DVGs) generated during the serial passaging of influenza A/Puerto Rico/8/1934 (H1N1) virus in embryonated chicken eggs. Deletions were the most abundant DVG type, predominantly accumulating in the polymerase-encoding segments. Notably, we identified and validated a novel class of multisegment DVGs arising from intersegment recombination events, providing evidence that the IAV RNA polymerase can detach from one genomic template and resume synthesis on another. Multisegment recombination primarily involved segments 1-3 but also occurred between other segment pairings. In specific lineages, certain multisegment DVGs reached high frequencies and persisted through multiple passages, suggesting they are not transient by-products of recombination but may possess features that support stable maintenance. Furthermore, multisegment DVGs were shown to be encapsidated within virions, similar to deletion DVGs. The observation of recombination between segments with limited sequence homology underscores the potential for complex recombination to expand IAV genetic diversity. These findings suggest recombination-driven DVGs represent a previously underappreciated mechanism in influenza virus evolution.
Keywords: RNA recombination; defective viral genomes; influenza A virus; multisegment recombination; next-generation sequencing; viral evolution.
Conflict of interest statement
Soraya Anisi and George Noble are PhD students partially funded by OVO Biomanufacturing Ltd. Rory Williams and Jack Hales are both employees of the company OVO Biomanufacturing Ltd. Phillip Gould is a co-founder and Chief Scientific Officer of OVO Biomanufacturing Ltd. William Collier is a co-founder and Chief Executive Officer of OVO Biomanufacturing. The authors declare there are no other conflicts of interest.
Figures





Similar articles
-
Diverse effects of coronavirus-defective viral genomes on the synthesis of IFNβ and ISG15 mRNAs and coronavirus replication.Virol J. 2025 Feb 14;22(1):37. doi: 10.1186/s12985-025-02654-5. Virol J. 2025. PMID: 39953551 Free PMC article.
-
Emergence and Evolution of Novel Reassortant Influenza A Viruses in Canines in Southern China.mBio. 2018 Jun 5;9(3):e00909-18. doi: 10.1128/mBio.00909-18. mBio. 2018. PMID: 29871917 Free PMC article.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. Cochrane Database Syst Rev. 2023. PMID: 36715243 Free PMC article.
-
Antigenic Characterization and Pandemic Risk Assessment of North American H1 Influenza A Viruses Circulating in Swine.Microbiol Spectr. 2022 Dec 21;10(6):e0178122. doi: 10.1128/spectrum.01781-22. Epub 2022 Nov 1. Microbiol Spectr. 2022. PMID: 36318009 Free PMC article.
-
Coronavirus Replication: Genomes, Subgenomic RNAs, and Defective Viral Genomes.Viruses. 2025 May 28;17(6):767. doi: 10.3390/v17060767. Viruses. 2025. PMID: 40573357 Free PMC article. Review.
References
-
- WHO Influenza (Seasonal) [(accessed on 5 May 2025)]. Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
-
- Memoli M.J., Athota R., Reed S., Czajkowski L., Bristol T., Proudfoot K., Hagey R., Voell J., Fiorentino C., Ademposi A., et al. The Natural History of Influenza Infection in the Severely Immunocompromised vs. Nonimmunocompromised Hosts. Clin. Infect. Dis. 2014;58:214–224. doi: 10.1093/cid/cit725. - DOI - PMC - PubMed
-
- Chan L., Alizadeh K., Alizadeh K., Fazel F., Kakish J.E., Karimi N., Knapp J.P., Mehrani Y., Minott J.A., Morovati S., et al. Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration. Vaccines. 2021;9:979. doi: 10.3390/vaccines9090979. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources